Pharming Group N.V. (PHAR) Current Assets (2019 - 2024)

Pharming (PHAR) has disclosed Current Assets for 6 consecutive years, with $278.4 million as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Current Assets fell 11.98% year-over-year to $278.4 million, compared with a TTM value of $278.4 million through Dec 2024, down 11.98%, and an annual FY2024 reading of $278.4 million, down 11.98% over the prior year.
  • Current Assets was $278.4 million for Q4 2024 at Pharming, down from $316.3 million in the prior quarter.
  • Across five years, Current Assets topped out at $316.3 million in Q4 2023 and bottomed at $249.4 million in Q4 2021.
  • Average Current Assets over 5 years is $275.5 million, with a median of $277.5 million recorded in 2022.
  • The sharpest move saw Current Assets skyrocketed 116.78% in 2020, then fell 11.98% in 2024.
  • Year by year, Current Assets stood at $255.6 million in 2020, then dropped by 2.39% to $249.4 million in 2021, then increased by 11.25% to $277.5 million in 2022, then increased by 14.0% to $316.3 million in 2023, then dropped by 11.98% to $278.4 million in 2024.
  • Business Quant data shows Current Assets for PHAR at $278.4 million in Q4 2024, $316.3 million in Q4 2023, and $277.5 million in Q4 2022.